(Q38815459)

English

Combined paclitaxel, cisplatin and fluorouracil therapy enhances ionizing radiation effects, inhibits migration and induces G0/G1 cell cycle arrest and apoptosis in oral carcinoma cell lines

scientific article published on 6 July 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

Combined paclitaxel, cisplatin and fluorouracil therapy enhances ionizing radiation effects, inhibits migration and induces G0/G1 cell cycle arrest and apoptosis in oral carcinoma cell lines (English)

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Eliete Neves Silva Guerra

8

object named as

Eliete Neves Silva Guerra

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

author name string

Silvia Taveira Elias

1

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

Gabriel Alvares Borges

2

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

Daniela Fortunato Rêgo

3

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

Luis Felipe Oliveira E Silva

4

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

Samuel Avelino

5

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

João Nunes DE Matos Neto

6

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

Luiz Alberto Simeoni

7

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

publication date

6 July 2015

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

Oncology Letters

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

10

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

3

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

1721-1727

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

Current treatment of head and neck squamous cell cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

9 September 2017

Elevated cyclin D1 expression is predictive for a benefit from TPF induction chemotherapy in oral squamous cell carcinoma patients with advanced nodal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

9 September 2017

Epithelial to mesenchymal transition in head and neck squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

9 September 2017

Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

9 September 2017

Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

9 September 2017

The molecular biology of head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

9 September 2017

Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

9 September 2017

Global epidemiology of oral and oropharyngeal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

9 September 2017

Current concepts in management of oral cancer--surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

9 September 2017

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

9 September 2017

Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

9 September 2017

The Hallmarks of Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

9 September 2017

Antitumor activity of cetuximab associated with the taxotere-cisplatin-fluorouracil (TPF) combination on an orthotopic head and neck cancer model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

9 September 2017

Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

14 September 2017

Impact of prolonged fraction delivery times simulating IMRT on cultured nasopharyngeal carcinoma cell killing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

14 September 2017

Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

14 September 2017

Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

22 June 2018

Causes of oral cancer--an appraisal of controversies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

31 August 2018

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533626

31 August 2018

Identifiers

10.3892/OL.2015.3458

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

6 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38815459&oldid=1788256166"